AI/ML Innovations' Tech2Heal Selected for Prestigious Health Tech Campus

Rhea-AI Summary

AI/ML Innovations Inc. (CSE:AIML, OTCQB:AIMLF) announced that its subsidiary, Tech2Heal SAS, has been selected as a founding participant in the PariSanté Health Tech Campus in Paris, France. This initiative aims to foster collaboration among leading health-tech entities to enhance research and innovation in e-health. Tech2Heal's recognition reflects its leadership in digital mental healthcare. The campus includes prominent players like Inserm and Health Data Hub, providing Tech2Heal access to a rich ecosystem of expertise to strengthen its healthcare solutions.

Positive

• Tech2Heal's selection as a founding participant in the prestigious PariSanté Health Tech Campus enhances its credibility and visibility in the health-tech sector.
• Participation in the campus provides Tech2Heal access to valuable resources and collaboration opportunities with leading health-tech researchers and companies.

Negative

• None.

TORONTO, ON / ACCESSWIRE / February 7, 2022 / AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce that its minority-owned subsidiary, Tech2Heal SAS, has been chosen as one of a small and select group of candidates, to be a founding participant in the PariSanté Health Tech Campus, located in Paris, France. The PariSanté Campus is described as the heart of e-health research and innovation in France. Its ambition is to mobilize and multiply the efforts of collective health-tech intelligence by bringing together thousands of individuals representing the finest researchers, public operators, universities, start-ups, and manufacturers in a unique and rich ecosystem conducive to innovation.

"Being chosen to participate in this highly specialized technology campus affords Tech2Heal the opportunity to leverage off of the expertise of some of the best-known health-tech companies that France has to offer," said Tim Daniels, Chairman of AI/ML Innovations. "As well, Tech2heal's selection reaffirms that they are being recognized as a leader amongst the emerging digital mental healthcare providers in France."

The Campus is anchored by a core group of entities which includes Inserm (France's National Institute of Health and Medical Research), Health Data Hub (a public company facilitating secure data access), Paris Sciences et Lettres University (a public research university), The Inria Paris Research Centre (National Institute for Research in Digital Science and Technology), and Agence du Numerique en Sante (Digital Health Agency of France). https://parisantecampus.fr/

About Tech2Heal https://www.tech2heal.com/

Tech2Heal is a Paris, France based digital healthcare innovator with a portfolio of wellness and health-tech products and services designed to improve an individual's mental well-being by utilizing a unique blend of proprietary digital assets, remote live counselling, and a physical wellness center. Tech2Health has developed a clinically supported and evidence-based methodology consisting of psychotherapies and non-medicinal interventions that apply body and mind healing techniques, delivered via a secure digital platform.

Tech2Health's premier product, Qookka Live, provides mental and emotional health preventive and support services to corporations and health insurers from within one cohesive app. Qookka Live affords simple, intuitive access to licensed therapists and their patients, and supplements these consultations with both digital courses and live sessions of wellness coaching in six areas: meditation, mindfulness, yoga, art therapy, Tai chi and Qi Qong.

About AI/ML Innovations Inc. https://aiml-innovations.com/

AI/ML Innovations Inc. has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence (AI) and machine learning (ML), with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. Through strategic partnerships with Health Gauge (70% owned by AIML), Tech2Heal (22% ownership commitment by AIML), AI Rx Inc. (70% owned by AIML) and other planned accretive investments, the Company continues to capitalize on expanding growth areas, to the benefit of all the Company's stakeholders. AI/ML's shares are traded on the Canadian Securities Exchange under the symbol "AIML", the OTCQB Venture Market under "AIMLF", and the Frankfurt Stock Exchange under "42FB".

On behalf of the Board of Directors
Tim Daniels, Executive Chairman

For more information about AI/ML Innovations:
For detailed information please visit our website or our filed documents at www.sedar.com
For further information: Blake Fallis at +1 (778) 405-0882 or info@aiml-innovations.com

Presentations:
Corporate video: https://www.youtube.com/watch?v=k2QSjo7clXc&feature=youtu.be
Official YouTube Channel: https://www.youtube.com/channel/UCCfOj2P_Fu3TOK6Jl1G9vEQ

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Cautionary and Forward-Looking Statements

Certain information in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of the Company, including but not limited to, the uncertainty of competition by other industry players, the impact of general economic conditions, industry conditions, dependence upon regulatory approvals and the ability to raise additional capital as may be needed in the future. Readers are cautioned that the assumptions used in preparing such information, although considered reasonable at the time of preparation, may prove imprecise and undue reliance should not be placed on forward-looking statements. Forward-looking statements in this press release are expressly qualified by this cautionary statement. The forward-looking statements in this press release are made as of the date of this press release, and the Company undertakes no obligations to update publicly or to revise any of the included forward-looking statements, whether because of new information, future events or otherwise, except as expressly required by applicable securities law.

SOURCE: AI/ML Innovations Inc.

View source version on accesswire.com:
https://www.accesswire.com/687375/AIML-Innovations-Tech2Heal-Selected-for-Prestigious-Health-Tech-Campus

FAQ

What is the significance of Tech2Heal's selection for the PariSanté Health Tech Campus?

Tech2Heal's selection is significant as it positions the company among elite health-tech innovators in France, offering access to valuable networking and research resources.

How does Tech2Heal's participation in the PariSanté Health Tech Campus affect AI/ML Innovations Inc.?

Tech2Heal's involvement can enhance AI/ML Innovations' portfolio and reputation in the digital health space, potentially leading to increased investment and growth opportunities.

Is AI/ML Innovations Inc. involved in any other health-tech initiatives?

Yes, AI/ML Innovations Inc. is involved in multiple health-tech initiatives through its subsidiaries, focusing on leveraging AI and ML to improve healthcare management solutions.

What are the key components of Tech2Heal's health-tech services?

Tech2Heal offers a blend of proprietary digital assets, remote counseling, and a physical wellness center, focusing on mental well-being through various therapeutic approaches.

What companies are part of the PariSanté Health Tech Campus?

The PariSanté Health Tech Campus includes notable organizations like Inserm, Health Data Hub, Paris Sciences et Lettres University, and the Inria Paris Research Centre.